HYDROCORTISONE ACETATE

HYDROCORTISONE ACETATE was reported 73916 times

HYDROCORTISONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN BOCAVIRUS INFECTION 113 0.5979
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 346 0.5180
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 1000 0.4993
3 LUPUS VULGARIS 611 0.4849
4 RHEUMATIC FEVER 2082 0.4666
5 SWOLLEN JOINT COUNT INCREASED 1484 0.4649
6 GRIP STRENGTH 106 0.4629
7 VAGINAL FLATULENCE 138 0.4554
8 C-REACTIVE PROTEIN 416 0.4488
9 LYMPHOID TISSUE HYPOPLASIA 68 0.4444
10 THYMUS HYPOPLASIA 73 0.4195
11 SLEEP DISORDER THERAPY 82 0.4141
12 TOPICAL STEROID WITHDRAWAL REACTION 158 0.4062
13 SWOLLEN JOINT COUNT 100 0.4000
14 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2831 0.3947
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 807 0.3891
16 FACET JOINT SYNDROME 1258 0.3860
17 RHEUMATOID FACTOR POSITIVE 2230 0.3857
18 DUODENAL ULCER PERFORATION 2804 0.3767
19 DISLOCATION OF VERTEBRA 774 0.3390
20 X-RAY ABNORMAL 595 0.3324
21 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 167 0.2977
22 CYSTITIS BACTERIAL 96 0.2840
23 ANALGESIC THERAPY 91 0.2835
24 CONGENITAL HIATUS HERNIA 63 0.2763
25 NOROVIRUS TEST POSITIVE 88 0.2708
26 HELICOBACTER INFECTION 2776 0.2698
27 STEROID DEPENDENCE 234 0.2665
28 APPENDICOLITH 103 0.2661
29 PEMPHIGUS 3316 0.2650
30 RETINITIS 453 0.2620
31 HAND DEFORMITY 3234 0.2463
32 STEROID WITHDRAWAL SYNDROME 245 0.2397
33 PERIPHERAL VENOUS DISEASE 949 0.2321
34 DRUG THERAPY 78 0.2301
35 CRANIOPHARYNGIOMA 76 0.2289
36 ADRENOCORTICAL INSUFFICIENCY ACUTE 436 0.2232
37 MUSCLE INJURY 1832 0.2209
38 HYPOCHOLESTEROLAEMIA 75 0.2125
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1375 0.2115
40 MYCOBACTERIUM CHELONAE INFECTION 155 0.2097
41 FOLLICULITIS 2173 0.2070
42 C-REACTIVE PROTEIN ABNORMAL 1306 0.2034
43 CATARRH 177 0.1958
44 PERICARDITIS 3261 0.1939
45 SECONDARY IMMUNODEFICIENCY 229 0.1885
46 PORPHYRIA ACUTE 264 0.1840
47 ABSCESS BACTERIAL 66 0.1818
48 SYNOVITIS 3251 0.1801
49 ADRENAL SUPPRESSION 150 0.1779
50 SERONEGATIVE ARTHRITIS 190 0.1658
51 BREAST CANCER STAGE III 1024 0.1580
52 GLOSSODYNIA 3367 0.1502
53 OVERLAP SYNDROME 104 0.1486
54 DRUG TOLERANCE DECREASED 393 0.1398
55 LIP DRY 1223 0.1345
56 HYPOFIBRINOGENAEMIA 128 0.1290
57 ONYCHOMADESIS 541 0.1288
58 GRIP STRENGTH DECREASED 1130 0.1283
59 HYPERCHOLESTEROLAEMIA 1208 0.1250
60 WOUND 3445 0.1231
61 LIVE BIRTH 986 0.1177
62 BONE EROSION 414 0.1169
63 JOINT RANGE OF MOTION DECREASED 1546 0.1152
64 ONYCHOMYCOSIS 498 0.1134
65 PSEUDOMONAL SEPSIS 197 0.1124
66 FEMALE GENITAL TRACT FISTULA 191 0.1118
67 WOUND INFECTION 1167 0.1065
68 SYSTEMIC LUPUS ERYTHEMATOSUS 3746 0.1054
69 BURSITIS 1278 0.1052
70 DEATH NEONATAL 141 0.1013
71 IRRITABLE BOWEL SYNDROME 2154 0.1004
72 AUTOIMMUNE DISORDER 979 0.1003
73 BURNS SECOND DEGREE 175 0.0997
74 PARAINFLUENZAE VIRUS INFECTION 151 0.0991
75 FEBRILE BONE MARROW APLASIA 413 0.0971
76 BLEPHAROSPASM 583 0.0925
77 HUMAN HERPESVIRUS 6 INFECTION 168 0.0888
78 FIBROMYALGIA 2135 0.0877
79 SECONDARY ADRENOCORTICAL INSUFFICIENCY 126 0.0834
80 ADRENAL INSUFFICIENCY 987 0.0813
81 CONTRAINDICATED PRODUCT ADMINISTERED 2462 0.0812
82 ENTEROBACTER INFECTION 133 0.0791
83 MATERNAL EXPOSURE TIMING UNSPECIFIED 284 0.0755
84 TYPE 2 DIABETES MELLITUS 2540 0.0754
85 LIVER INJURY 1814 0.0738
86 RADICULOPATHY 192 0.0728
87 INFUSION RELATED REACTION 4723 0.0712
88 BODY TEMPERATURE FLUCTUATION 148 0.0710
89 CHRONIC SINUSITIS 264 0.0703
90 PROCTITIS 196 0.0699
91 IMPAIRED HEALING 2278 0.0693
92 DRUG LEVEL BELOW THERAPEUTIC 381 0.0690
93 VIRAEMIA 93 0.0671
94 DIABETES INSIPIDUS 161 0.0668
95 DIFFUSE ALVEOLAR DAMAGE 75 0.0652
96 NAIL DISORDER 569 0.0650
97 OBESITY 1029 0.0645
98 SCIATICA 1023 0.0641
99 PITUITARY TUMOUR BENIGN 104 0.0637
100 FINGER DEFORMITY 308 0.0635
101 PRODUCT LABEL CONFUSION 352 0.0603
102 EXOSTOSIS 541 0.0592
103 WALKING AID USER 385 0.0583
104 ARTHROPATHY 3228 0.0580
105 HYPOPITUITARISM 101 0.0580
106 PULMONARY FIBROSIS 1109 0.0578
107 FAECAL CALPROTECTIN INCREASED 182 0.0574
108 PSORIATIC ARTHROPATHY 2327 0.0573
109 BRONCHIECTASIS 377 0.0559
110 PRESCRIBED OVERDOSE 1081 0.0558
111 EYE INJURY 169 0.0556
112 PUSTULAR PSORIASIS 191 0.0556
113 SKIN WEEPING 198 0.0554
114 CORTISOL DECREASED 63 0.0551
115 HIP ARTHROPLASTY 835 0.0545
116 LOWER LIMB FRACTURE 1043 0.0542
117 LOWER RESPIRATORY TRACT INFECTION 2458 0.0540
118 CYTOMEGALOVIRUS CHORIORETINITIS 105 0.0538
119 HYPERPHOSPHATAEMIA 114 0.0530
120 HYPOPNOEA 182 0.0524
121 BLOOD CHOLESTEROL INCREASED 2433 0.0521
122 LUPUS-LIKE SYNDROME 467 0.0514
123 ULCER HAEMORRHAGE 347 0.0512
124 HEPATIC ENZYME INCREASED 3480 0.0510
125 BREAST CANCER STAGE II 417 0.0501
126 DISCOMFORT 3049 0.0499
127 BLISTER 2795 0.0497
128 RHINOVIRUS INFECTION 190 0.0488
129 HYPOPHYSITIS 98 0.0487
130 GASTROENTERITIS NOROVIRUS 64 0.0482
131 PNEUMATOSIS INTESTINALIS 137 0.0480
132 INTENTIONAL PRODUCT USE ISSUE 4161 0.0475
133 THERAPEUTIC PRODUCT EFFECT DECREASED 2109 0.0470
134 BLOOD PRESSURE FLUCTUATION 1128 0.0469
135 COELIAC DISEASE 456 0.0464
136 RED BLOOD CELL SEDIMENTATION RATE INCREASED 502 0.0453
137 RASH VESICULAR 219 0.0452
138 GAIT INABILITY 1491 0.0446
139 ANAL FISSURE 237 0.0441
140 STRONGYLOIDIASIS 70 0.0433
141 ADRENAL DISORDER 82 0.0427
142 APLASTIC ANAEMIA 223 0.0427
143 BLOOD PHOSPHORUS INCREASED 116 0.0424
144 CONGENITAL ANOMALY 324 0.0418
145 ALCOHOL POISONING 112 0.0418
146 PRESCRIBED UNDERDOSE 829 0.0415
147 BACK INJURY 450 0.0413
148 SWELLING 3852 0.0411
149 NORMAL NEWBORN 223 0.0410
150 FOOT DEFORMITY 454 0.0409
151 STOMATITIS 2480 0.0408
152 SPONDYLITIS 148 0.0407
153 JOINT DISLOCATION 418 0.0395
154 CUSHINGOID 125 0.0389
155 DRUG LEVEL ABOVE THERAPEUTIC 178 0.0388
156 KNEE ARTHROPLASTY 804 0.0381
157 WHEEZING 2254 0.0380
158 NIGHT SWEATS 1204 0.0373
159 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 636 0.0371
160 FREQUENT BOWEL MOVEMENTS 1000 0.0370
161 BLOOD PRESSURE DIASTOLIC DECREASED 270 0.0365
162 SERUM SICKNESS 101 0.0362
163 OSTEOARTHRITIS 1519 0.0358
164 MATERNAL EXPOSURE DURING PREGNANCY 3181 0.0357
165 DRUG INTOLERANCE 3415 0.0353
166 BRONCHOPULMONARY ASPERGILLOSIS 272 0.0350
167 INFUSION SITE REACTION 104 0.0348
168 CLOSTRIDIUM DIFFICILE COLITIS 364 0.0343
169 C-REACTIVE PROTEIN INCREASED 1248 0.0343
170 POOR VENOUS ACCESS 351 0.0339
171 LEUKOENCEPHALOPATHY 126 0.0338
172 ASPERGILLUS INFECTION 218 0.0332
173 INJURY 2306 0.0328
174 ERYTHEMA NODOSUM 115 0.0327
175 MOBILITY DECREASED 2324 0.0323
176 OEDEMA 1753 0.0323
177 RHEUMATOID ARTHRITIS 3627 0.0319
178 DRUG SPECIFIC ANTIBODY PRESENT 206 0.0316
179 DRUG LEVEL DECREASED 321 0.0315
180 HYPERTRIGLYCERIDAEMIA 184 0.0314
181 TREATMENT FAILURE 2593 0.0313
182 INFLAMMATION 1604 0.0310
183 ILL-DEFINED DISORDER 1866 0.0307
184 JOINT SWELLING 3652 0.0302
185 MUSCULOSKELETAL STIFFNESS 2626 0.0299
186 BACTERIAL INFECTION 557 0.0298
187 ROAD TRAFFIC ACCIDENT 1244 0.0297
188 GINGIVAL PAIN 235 0.0295
189 SLEEP DISORDER 2074 0.0294
190 ENTERITIS 188 0.0293
191 ESCHERICHIA BACTERAEMIA 69 0.0293
192 GENERAL PHYSICAL HEALTH DETERIORATION 3392 0.0293
193 TASTE DISORDER 592 0.0292
194 IRON DEFICIENCY 131 0.0291
195 COLITIS ULCERATIVE 1285 0.0287
196 TEMPERATURE REGULATION DISORDER 64 0.0287
197 KOUNIS SYNDROME 65 0.0286
198 DELIRIUM 986 0.0284
199 CYTOMEGALOVIRUS VIRAEMIA 126 0.0283
200 BLOOD PRESSURE DIASTOLIC INCREASED 129 0.0279
201 OESOPHAGEAL CANDIDIASIS 111 0.0278
202 LIVER FUNCTION TEST INCREASED 598 0.0278
203 APHTHOUS ULCER 216 0.0278
204 LUNG DISORDER 1364 0.0278
205 RHINITIS 224 0.0278
206 HEPATIC CIRRHOSIS 521 0.0277
207 HYPOPHOSPHATAEMIA 204 0.0276
208 RESPIRATORY SYMPTOM 78 0.0274
209 EPILEPSY 835 0.0273
210 PLEURITIC PAIN 75 0.0271
211 KLEBSIELLA INFECTION 137 0.0271
212 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 137 0.0270
213 EXPOSURE DURING PREGNANCY 1672 0.0269
214 PROCTALGIA 170 0.0264
215 HYPERCAPNIA 79 0.0262
216 MYOSITIS 235 0.0262
217 BODY TEMPERATURE DECREASED 255 0.0259
218 SYSTEMIC CANDIDA 65 0.0259
219 THERAPY NON-RESPONDER 1162 0.0258
220 HYPERNATRAEMIA 128 0.0257
221 SPINAL FUSION SURGERY 104 0.0256
222 STAPHYLOCOCCAL SEPSIS 125 0.0253
223 CARDIAC MURMUR 218 0.0252
224 DRUG-INDUCED LIVER INJURY 790 0.0252
225 ABDOMINAL DISCOMFORT 4216 0.0251
226 LARGE INTESTINAL ULCER 68 0.0250
227 BLOOD CULTURE POSITIVE 75 0.0250
228 GASTROINTESTINAL DISORDER 2243 0.0250
229 OXYGEN SATURATION ABNORMAL 71 0.0250
230 VENOUS THROMBOSIS 98 0.0249
231 IMPAIRED QUALITY OF LIFE 357 0.0248
232 WEIGHT FLUCTUATION 259 0.0247
233 PAROSMIA 186 0.0246
234 ENTEROCOCCAL INFECTION 119 0.0246
235 LIVER DISORDER 1075 0.0242
236 FEBRILE NEUTROPENIA 1603 0.0241
237 MUCOUS STOOLS 119 0.0240
238 ADVERSE REACTION 318 0.0240
239 ORAL CANDIDIASIS 313 0.0237
240 MUCOSAL INFLAMMATION 614 0.0234
241 MUSCULOSKELETAL PAIN 1225 0.0234
242 EAR INFECTION 621 0.0233
243 RECTAL HAEMORRHAGE 996 0.0232
244 EAR PAIN 446 0.0229
245 DERMATITIS EXFOLIATIVE GENERALISED 79 0.0227
246 NEUTROPENIC SEPSIS 162 0.0227
247 HEART RATE DECREASED 789 0.0224
248 PREGNANCY 449 0.0224
249 GENERAL SYMPTOM 168 0.0224
250 SUSPECTED OFF LABEL USE 101 0.0223
251 SINUSITIS 2286 0.0223
252 INFUSION SITE EXTRAVASATION 138 0.0221
253 DRY MOUTH 1797 0.0221
254 CONDITION AGGRAVATED 6733 0.0221
255 BACTERIAL SEPSIS 72 0.0221
256 DIASTOLIC DYSFUNCTION 68 0.0220
257 CONTUSION 2103 0.0218
258 NEOPLASM RECURRENCE 73 0.0215
259 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 364 0.0214
260 HYPERSENSITIVITY 3964 0.0213
261 BLOOD URIC ACID INCREASED 123 0.0213
262 GRAFT VERSUS HOST DISEASE 151 0.0210
263 ANAL FISTULA 112 0.0210
264 RESPIRATORY ACIDOSIS 82 0.0208
265 SKIN ATROPHY 120 0.0208
266 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 989 0.0206
267 JOINT STIFFNESS 540 0.0206
268 RALES 119 0.0205
269 DISABILITY 405 0.0205
270 BLOOD PRESSURE SYSTOLIC INCREASED 399 0.0204
271 ALOPECIA 4004 0.0204
272 MULTIPLE ORGAN DYSFUNCTION SYNDROME 576 0.0203
273 HERPES SIMPLEX 132 0.0203
274 AORTIC STENOSIS 69 0.0198
275 DYSPEPSIA 1949 0.0198
276 BENIGN PROSTATIC HYPERPLASIA 102 0.0197
277 HEART RATE IRREGULAR 445 0.0197
278 SEPTIC SHOCK 855 0.0196
279 RESPIRATORY RATE INCREASED 174 0.0196
280 FISTULA 220 0.0196
281 VAGINAL DISCHARGE 198 0.0195
282 MIGRAINE 1854 0.0194
283 HYPERTRANSAMINASAEMIA 135 0.0194
284 PSEUDOMONAS INFECTION 166 0.0193
285 RESPIRATORY DISORDER 576 0.0192
286 CONFUSIONAL STATE 3029 0.0187
287 APPENDICITIS 175 0.0187
288 HYPOALBUMINAEMIA 145 0.0186
289 BODY TEMPERATURE INCREASED 377 0.0185
290 INFECTION 2672 0.0184
291 OSTEOPOROSIS 756 0.0184
292 ANAL ABSCESS 99 0.0184
293 NEPHROGENIC ANAEMIA 85 0.0183
294 FUNCTIONAL GASTROINTESTINAL DISORDER 63 0.0182
295 POLYARTHRITIS 96 0.0182
296 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 173 0.0181
297 HYPERTENSION 3826 0.0180
298 RED CELL DISTRIBUTION WIDTH INCREASED 75 0.0180
299 STAPHYLOCOCCAL BACTERAEMIA 78 0.0179
300 URTICARIA 2975 0.0177
301 SKIN WARM 103 0.0177
302 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1257 0.0177
303 HYPOAESTHESIA 2639 0.0176
304 CANDIDA INFECTION 294 0.0174
305 BACTERAEMIA 206 0.0173
306 MYASTHENIA GRAVIS 140 0.0173
307 VENOOCCLUSIVE LIVER DISEASE 85 0.0172
308 CARDIOGENIC SHOCK 245 0.0171
309 PARAESTHESIA ORAL 245 0.0170
310 PNEUMOCYSTIS JIROVECII PNEUMONIA 169 0.0168
311 PERIPHERAL SWELLING 2590 0.0168
312 PRODUCT USE ISSUE 3146 0.0167
313 HEPATITIS 427 0.0167
314 COLITIS 631 0.0166
315 WOUND SECRETION 65 0.0166
316 NASOPHARYNGITIS 3056 0.0166
317 HYPERBILIRUBINAEMIA 171 0.0165
318 HAEMATOCHEZIA 907 0.0164
319 SKIN INFECTION 184 0.0164
320 ECZEMA 849 0.0162
321 TOXIC EPIDERMAL NECROLYSIS 245 0.0161
322 WEIGHT INCREASED 3612 0.0161
323 HAEMORRHOIDS 313 0.0160
324 VENTRICULAR FIBRILLATION 177 0.0159
325 BACK DISORDER 258 0.0159
326 MEDICATION ERROR 872 0.0157
327 DRUG TOLERANCE 79 0.0156
328 PAPULE 110 0.0156
329 BREATH SOUNDS ABNORMAL 76 0.0154
330 DEFAECATION URGENCY 107 0.0153
331 TROPONIN INCREASED 115 0.0151
332 ENCEPHALITIS 104 0.0150
333 ATELECTASIS 145 0.0150
334 TUMOUR LYSIS SYNDROME 132 0.0150
335 PURULENT DISCHARGE 64 0.0150
336 NEURALGIA 361 0.0148
337 UVEITIS 201 0.0148
338 HYPONATRAEMIA 834 0.0148
339 AMNESIA 957 0.0147
340 RASH 6406 0.0147
341 VIRAL INFECTION 486 0.0146
342 HYPERLIPIDAEMIA 174 0.0145
343 ASTHMA 1645 0.0145
344 ORAL DISORDER 106 0.0144
345 HYPOKALAEMIA 663 0.0143
346 SKIN PLAQUE 121 0.0143
347 HYDROCEPHALUS 78 0.0143
348 TUBULOINTERSTITIAL NEPHRITIS 268 0.0143
349 VAGINAL INFECTION 67 0.0142
350 ARTERIOSCLEROSIS CORONARY ARTERY 94 0.0142
351 CLOSTRIDIUM DIFFICILE INFECTION 309 0.0141
352 UPPER RESPIRATORY TRACT INFECTION 649 0.0140
353 ABSCESS 223 0.0140
354 BLOOD THYROID STIMULATING HORMONE DECREASED 63 0.0139
355 MACULAR DEGENERATION 164 0.0137
356 PYREXIA 4740 0.0137
357 THERAPEUTIC RESPONSE SHORTENED 454 0.0137
358 OBSTRUCTIVE AIRWAYS DISORDER 152 0.0137
359 ACUTE RESPIRATORY DISTRESS SYNDROME 240 0.0136
360 HYPOVOLAEMIC SHOCK 65 0.0136
361 DIARRHOEA HAEMORRHAGIC 125 0.0134
362 PRODUCT USE IN UNAPPROVED INDICATION 3268 0.0132
363 ARTHRITIS 1033 0.0131
364 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2365 0.0131
365 INFUSION SITE SWELLING 82 0.0130
366 APPETITE DISORDER 86 0.0130
367 ARTHRALGIA 5394 0.0130
368 DRUG LEVEL INCREASED 214 0.0129
369 INFLAMMATORY MARKER INCREASED 64 0.0129
370 GASTROOESOPHAGEAL REFLUX DISEASE 1035 0.0128
371 ADVERSE DRUG REACTION 1137 0.0126
372 SEPSIS 1410 0.0126
373 SKIN LESION 344 0.0125
374 OFF LABEL USE 10963 0.0125
375 INFUSION SITE PAIN 161 0.0125
376 MUSCULAR WEAKNESS 1418 0.0125
377 NECK PAIN 697 0.0125
378 END STAGE RENAL DISEASE 227 0.0124
379 FAILURE TO THRIVE 64 0.0123
380 PRODUCT ADMINISTRATION INTERRUPTED 96 0.0122
381 ABDOMINAL PAIN UPPER 2509 0.0122
382 DIVERTICULUM 86 0.0121
383 TACHYCARDIA 1075 0.0121
384 RESPIRATORY DISTRESS 333 0.0121
385 ASPIRATION 132 0.0120
386 OXYGEN SATURATION DECREASED 673 0.0120
387 DECREASED APPETITE 2761 0.0119
388 CHEST PAIN 2200 0.0119
389 ABDOMINAL PAIN 2761 0.0119
390 SKIN SWELLING 103 0.0119
391 OEDEMA PERIPHERAL 1442 0.0118
392 ADVERSE EVENT 1087 0.0118
393 PRURITUS 4529 0.0118
394 ENTEROCOLITIS 68 0.0118
395 ACIDOSIS 90 0.0118
396 HAEMODYNAMIC INSTABILITY 89 0.0117
397 ANORECTAL DISCOMFORT 62 0.0117
398 LUNG INFILTRATION 103 0.0116
399 ACUTE RESPIRATORY FAILURE 224 0.0116
400 TACHYPNOEA 158 0.0116
401 DERMATITIS 242 0.0115
402 BLOOD CALCIUM INCREASED 101 0.0115
403 IMPAIRED WORK ABILITY 246 0.0115
404 PULMONARY HAEMORRHAGE 90 0.0115
405 STREPTOCOCCAL INFECTION 64 0.0115
406 RASH PRURITIC 622 0.0115
407 ENCEPHALOPATHY 281 0.0114
408 NEUROTOXICITY 200 0.0114
409 CYTOKINE RELEASE SYNDROME 228 0.0114
410 PARAESTHESIA 1785 0.0113
411 ABDOMINAL DISTENSION 1184 0.0113
412 MEMORY IMPAIRMENT 1556 0.0113
413 TENDERNESS 118 0.0113
414 ORAL HERPES 221 0.0113
415 MOUTH ULCERATION 238 0.0113
416 HYPERGLYCAEMIA 411 0.0113
417 IRON DEFICIENCY ANAEMIA 104 0.0113
418 FEELING HOT 688 0.0112
419 SWOLLEN TONGUE 350 0.0112
420 SKIN FISSURES 219 0.0112
421 ANAPHYLACTIC REACTION 619 0.0112
422 FLANK PAIN 105 0.0112
423 THROMBOTIC MICROANGIOPATHY 109 0.0112
424 SKIN HYPERPIGMENTATION 96 0.0112
425 GASTROENTERITIS 163 0.0112
426 PHARYNGITIS STREPTOCOCCAL 120 0.0111
427 DISSEMINATED INTRAVASCULAR COAGULATION 156 0.0111
428 WEIGHT DECREASED 3073 0.0110
429 ANAL INCONTINENCE 99 0.0110
430 MALNUTRITION 123 0.0110
431 HYPOXIA 387 0.0110
432 ASCITES 323 0.0110
433 BLOOD PRESSURE INCREASED 1678 0.0110
434 STAPHYLOCOCCAL INFECTION 361 0.0109
435 ESCHERICHIA INFECTION 90 0.0109
436 POLYURIA 89 0.0109
437 LOWER GASTROINTESTINAL HAEMORRHAGE 80 0.0108
438 CROHN'S DISEASE 74 0.0108
439 INFUSION SITE ERYTHEMA 91 0.0108
440 MULTI-ORGAN FAILURE 186 0.0107
441 SLEEP APNOEA SYNDROME 205 0.0107
442 TOOTH INFECTION 141 0.0107
443 CONCOMITANT DISEASE AGGRAVATED 66 0.0107
444 HYDRONEPHROSIS 80 0.0107
445 ULCER 170 0.0107
446 SKIN LACERATION 116 0.0107
447 GENERALISED OEDEMA 132 0.0107
448 RESPIRATORY FAILURE 775 0.0106
449 LIPASE INCREASED 81 0.0106
450 PALLOR 287 0.0105
451 FUNGAL INFECTION 351 0.0105
452 PNEUMONIA 3409 0.0105
453 ELECTROLYTE IMBALANCE 122 0.0105
454 PANCREATITIS 554 0.0105
455 TRICUSPID VALVE INCOMPETENCE 83 0.0104
456 HYPERTHYROIDISM 151 0.0104
457 RASH ERYTHEMATOUS 498 0.0104
458 CYTOMEGALOVIRUS INFECTION 173 0.0104
459 ARTHROPOD BITE 77 0.0104
460 OSTEOPENIA 157 0.0103
461 IMMUNOSUPPRESSION 91 0.0103
462 GOUT 185 0.0103
463 PERIPHERAL COLDNESS 141 0.0103
464 COAGULOPATHY 171 0.0103
465 MUSCLE SPASTICITY 125 0.0102
466 ASPHYXIA 83 0.0102
467 PANCYTOPENIA 563 0.0101
468 MYOPATHY 87 0.0101
469 SINUS TACHYCARDIA 143 0.0101
470 BOWEL MOVEMENT IRREGULARITY 77 0.0100
471 SCRATCH 106 0.0100
472 VOMITING 4706 0.0100
473 PAIN 6059 0.0099
474 FEELING COLD 274 0.0098
475 CORONAVIRUS INFECTION 65 0.0098
476 LYMPHOPENIA 139 0.0098
477 PRODUCTIVE COUGH 469 0.0098
478 CELLULITIS 495 0.0098
479 FATIGUE 7634 0.0098
480 CYANOSIS 154 0.0098
481 SKIN EXFOLIATION 821 0.0097
482 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
483 GASTROINTESTINAL INFLAMMATION 76 0.0097
484 WHITE BLOOD CELL COUNT INCREASED 372 0.0097
485 HEPATOCELLULAR INJURY 137 0.0097
486 MALAISE 4236 0.0096
487 URINE OUTPUT DECREASED 84 0.0096
488 ORAL PAIN 215 0.0096
489 INSOMNIA 2556 0.0096
490 SPUTUM DISCOLOURED 91 0.0096
491 SKIN REACTION 135 0.0096
492 LOW BIRTH WEIGHT BABY 76 0.0096
493 SPINAL OSTEOARTHRITIS 84 0.0096
494 DEPRESSION 2169 0.0095
495 RESPIRATORY SYNCYTIAL VIRUS INFECTION 83 0.0095
496 BRONCHOSPASM 136 0.0095
497 GAIT DISTURBANCE 1813 0.0095
498 MUSCLE SPASMS 1726 0.0094
499 PAIN IN EXTREMITY 2770 0.0094
500 HYPERCALCAEMIA 116 0.0094
501 HYPOTHERMIA 95 0.0094
502 HAEMATOCRIT DECREASED 186 0.0094
503 MICTURITION URGENCY 107 0.0094
504 VASCULITIS 109 0.0093
505 FAECES SOFT 68 0.0093
506 RASH MACULO-PAPULAR 206 0.0093
507 IMMUNODEFICIENCY 138 0.0092
508 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 95 0.0092
509 DYSPNOEA 5225 0.0092
510 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 69 0.0092
511 ERYTHEMA 1890 0.0092
512 HEPATIC CYTOLYSIS 117 0.0092
513 EJECTION FRACTION DECREASED 142 0.0091
514 TOOTH ABSCESS 93 0.0091
515 DERMATITIS CONTACT 104 0.0091
516 OROPHARYNGEAL PAIN 843 0.0091
517 CIRCULATORY COLLAPSE 155 0.0091
518 RHINORRHOEA 587 0.0091
519 DEEP VEIN THROMBOSIS 590 0.0091
520 BLOOD MAGNESIUM DECREASED 78 0.0090
521 BLOOD SODIUM DECREASED 170 0.0090
522 CYSTITIS 286 0.0090
523 PANCREATITIS ACUTE 200 0.0089
524 BLOOD TEST ABNORMAL 125 0.0089
525 CHEST DISCOMFORT 907 0.0088
526 THROMBOCYTOPENIA 987 0.0088
527 PLEURAL EFFUSION 535 0.0088
528 HAEMOPTYSIS 244 0.0087
529 INTESTINAL PERFORATION 98 0.0087
530 PNEUMONIA BACTERIAL 80 0.0087
531 THERAPEUTIC RESPONSE DECREASED 528 0.0087
532 DEVICE RELATED INFECTION 134 0.0087
533 HYPOTHYROIDISM 277 0.0087
534 JOINT INJURY 185 0.0087
535 PULMONARY EMBOLISM 819 0.0086
536 HYPOTENSION 1722 0.0086
537 PSORIASIS 1121 0.0086
538 SKIN DISORDER 285 0.0085
539 PYELONEPHRITIS 74 0.0085
540 ASTHENIA 3211 0.0085
541 CARDIOMEGALY 105 0.0085
542 OESOPHAGITIS 93 0.0085
543 SCAB 97 0.0085
544 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 70 0.0085
545 BRONCHITIS 628 0.0085
546 ERYTHEMA MULTIFORME 79 0.0085
547 BLOOD ALBUMIN DECREASED 67 0.0084
548 HEADACHE 5288 0.0084
549 CHILLS 988 0.0084
550 EMPHYSEMA 85 0.0084
551 ACUTE KIDNEY INJURY 1288 0.0084
552 PREMATURE DELIVERY 134 0.0084
553 CHOLESTASIS 161 0.0084
554 UNRESPONSIVE TO STIMULI 216 0.0084
555 GASTROINTESTINAL INFECTION 75 0.0084
556 TRANSAMINASES INCREASED 186 0.0084
557 CONJUNCTIVITIS 155 0.0083
558 DERMATITIS ALLERGIC 105 0.0083
559 DIARRHOEA 5385 0.0083
560 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 457 0.0083
561 SECRETION DISCHARGE 104 0.0083
562 OROPHARYNGEAL DISCOMFORT 75 0.0083
563 INJECTION SITE REACTION 569 0.0083
564 LABORATORY TEST ABNORMAL 244 0.0083
565 SEASONAL ALLERGY 117 0.0083
566 PULMONARY MASS 123 0.0082
567 BLOOD PRESSURE DECREASED 548 0.0082
568 DERMATITIS ATOPIC 430 0.0081
569 PHARYNGITIS 101 0.0081
570 FULL BLOOD COUNT ABNORMAL 86 0.0081
571 RASH MACULAR 283 0.0081
572 LUNG INFECTION 125 0.0080
573 INTESTINAL OBSTRUCTION 303 0.0080
574 HYPOCALCAEMIA 152 0.0080
575 HYPERKALAEMIA 281 0.0080
576 BLOOD IRON DECREASED 95 0.0080
577 POST PROCEDURAL INFECTION 65 0.0080
578 HEART RATE INCREASED 790 0.0080
579 SMALL INTESTINAL OBSTRUCTION 98 0.0080
580 STEVENS-JOHNSON SYNDROME 177 0.0080
581 RESPIRATORY TRACT INFECTION 206 0.0079
582 PNEUMONITIS 215 0.0079
583 LYMPHADENOPATHY 278 0.0078
584 EMBOLISM 65 0.0078
585 SKIN HAEMORRHAGE 116 0.0078
586 TRANSFUSION 82 0.0078
587 LIP SWELLING 260 0.0078
588 THROAT TIGHTNESS 210 0.0078
589 GAMMA-GLUTAMYLTRANSFERASE INCREASED 172 0.0078
590 THROAT IRRITATION 348 0.0077
591 FLUID RETENTION 394 0.0077
592 NASAL CONGESTION 455 0.0077
593 PERICARDIAL EFFUSION 179 0.0077
594 STATUS EPILEPTICUS 87 0.0077
595 HYPOGLYCAEMIA 372 0.0077
596 ANURIA 66 0.0077
597 RENAL TUBULAR NECROSIS 75 0.0076
598 HYPOMAGNESAEMIA 106 0.0076
599 POLYNEUROPATHY 91 0.0076
600 GASTROENTERITIS VIRAL 137 0.0076
601 NERVE COMPRESSION 70 0.0076
602 FACE OEDEMA 127 0.0075
603 BRAIN NEOPLASM 69 0.0075
604 INCONTINENCE 79 0.0075
605 ANAEMIA 1414 0.0074
606 CYST 92 0.0074
607 FACIAL PARALYSIS 63 0.0074
608 ANXIETY 2102 0.0074
609 HEPATOTOXICITY 164 0.0074
610 NAUSEA 5826 0.0074
611 SKIN ULCER 190 0.0073
612 SINUS BRADYCARDIA 71 0.0073
613 TINNITUS 337 0.0073
614 NEUTROPHIL COUNT INCREASED 75 0.0073
615 CONSTIPATION 1592 0.0073
616 DIZZINESS 3636 0.0073
617 BACK PAIN 1692 0.0073
618 NEUROPATHY PERIPHERAL 691 0.0073
619 UROSEPSIS 67 0.0073
620 FLUSHING 738 0.0073
621 FOOT FRACTURE 137 0.0072
622 CHOLECYSTITIS 86 0.0072
623 ANKLE FRACTURE 111 0.0072
624 ILEUS 89 0.0072
625 NEPHROLITHIASIS 328 0.0071
626 BLOOD CREATININE INCREASED 466 0.0071
627 SHOCK 164 0.0071
628 LEUKOCYTOSIS 129 0.0071
629 LEUKOPENIA 356 0.0071
630 DYSPNOEA EXERTIONAL 267 0.0071
631 DRUG INEFFECTIVE 9325 0.0071
632 BONE MARROW FAILURE 143 0.0070
633 ANGIOEDEMA 311 0.0070
634 UNDERDOSE 511 0.0070
635 METABOLIC ACIDOSIS 223 0.0070
636 COVID-19 PNEUMONIA 82 0.0069
637 URINARY TRACT INFECTION 1180 0.0069
638 SWELLING FACE 450 0.0069
639 HIDRADENITIS 63 0.0069
640 ACCIDENTAL OVERDOSE 252 0.0069
641 PNEUMOTHORAX 109 0.0069
642 CYTOPENIA 84 0.0069
643 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 358 0.0069
644 PROCEDURAL PAIN 190 0.0068
645 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 176 0.0068
646 ALANINE AMINOTRANSFERASE INCREASED 419 0.0068
647 BRAIN OEDEMA 86 0.0068
648 FOETAL EXPOSURE DURING PREGNANCY 552 0.0068
649 RED BLOOD CELL COUNT DECREASED 194 0.0068
650 LOCALISED INFECTION 164 0.0068
651 CHRONIC KIDNEY DISEASE 514 0.0068
652 COVID-19 1185 0.0067
653 NEUTROPENIA 917 0.0067
654 FLUID OVERLOAD 98 0.0067
655 PAIN IN JAW 190 0.0067
656 COUGH 1874 0.0067
657 PHOTOPHOBIA 125 0.0066
658 PREMATURE BABY 200 0.0066
659 EYE DISCHARGE 69 0.0066
660 DYSURIA 244 0.0066
661 ASPARTATE AMINOTRANSFERASE INCREASED 351 0.0066
662 DEHYDRATION 881 0.0066
663 ORTHOSTATIC HYPOTENSION 115 0.0066
664 SUPRAVENTRICULAR TACHYCARDIA 63 0.0066
665 VERTIGO 401 0.0066
666 BLOOD UREA INCREASED 110 0.0066
667 HIATUS HERNIA 85 0.0066
668 DRY SKIN 873 0.0065
669 VISUAL IMPAIRMENT 809 0.0065
670 ABDOMINAL PAIN LOWER 165 0.0065
671 PNEUMONIA ASPIRATION 163 0.0065
672 SKIN DISCOLOURATION 299 0.0065
673 BLOOD LACTATE DEHYDROGENASE INCREASED 103 0.0065
674 SPINAL PAIN 76 0.0065
675 VENTRICULAR TACHYCARDIA 107 0.0065
676 HEPATIC FAILURE 195 0.0065
677 EYE INFECTION 73 0.0065
678 INCORRECT PRODUCT ADMINISTRATION DURATION 140 0.0065
679 MYOCARDITIS 74 0.0064
680 GASTRITIS 169 0.0064
681 BASAL CELL CARCINOMA 100 0.0064
682 TOOTHACHE 116 0.0064
683 HEPATIC STEATOSIS 119 0.0064
684 NIGHTMARE 221 0.0064
685 PULMONARY OEDEMA 286 0.0064
686 INFLUENZA 711 0.0064
687 EYE SWELLING 237 0.0064
688 HYPOAESTHESIA ORAL 96 0.0064
689 CARDIOMYOPATHY 94 0.0064
690 QUALITY OF LIFE DECREASED 85 0.0063
691 MUSCULOSKELETAL CHEST PAIN 98 0.0063
692 BLOOD CALCIUM DECREASED 71 0.0063
693 MENTAL STATUS CHANGES 175 0.0063
694 GENERALISED TONIC-CLONIC SEIZURE 104 0.0063
695 RENAL FAILURE 834 0.0063
696 LETHARGY 361 0.0063
697 ECONOMIC PROBLEM 95 0.0063
698 BRADYCARDIA 332 0.0063
699 ANAPHYLACTIC SHOCK 161 0.0062
700 ATAXIA 74 0.0062
701 LYMPHOCYTE COUNT DECREASED 110 0.0062
702 KIDNEY INFECTION 122 0.0062
703 RASH PAPULAR 139 0.0062
704 POOR QUALITY SLEEP 133 0.0062
705 TOOTH FRACTURE 68 0.0062
706 DRUG TOXICITY 84 0.0062
707 NEPHROPATHY TOXIC 69 0.0061
708 TENDONITIS 95 0.0061
709 PRESYNCOPE 149 0.0061
710 BLOOD BILIRUBIN INCREASED 165 0.0061
711 LACRIMATION INCREASED 184 0.0061
712 OSTEOMYELITIS 110 0.0061
713 MYOCARDIAL ISCHAEMIA 69 0.0061
714 HAEMOGLOBIN DECREASED 622 0.0061
715 RENAL FAILURE ACUTE 257 0.0061
716 NODULE 79 0.0060
717 PETECHIAE 63 0.0060
718 TREATMENT NONCOMPLIANCE 328 0.0060
719 DIABETES MELLITUS 452 0.0059
720 CAESAREAN SECTION 69 0.0059
721 MITRAL VALVE INCOMPETENCE 67 0.0059
722 DISEASE RECURRENCE 281 0.0059
723 PLATELET COUNT INCREASED 77 0.0059
724 COLD SWEAT 104 0.0059
725 GALLBLADDER DISORDER 105 0.0059
726 CORONARY ARTERY DISEASE 178 0.0059
727 EYE PRURITUS 197 0.0059
728 PALPITATIONS 686 0.0059
729 HERPES ZOSTER 336 0.0058
730 AGRANULOCYTOSIS 108 0.0058
731 BRAIN FOG 91 0.0058
732 SOMNOLENCE 1169 0.0058
733 BLOOD ALKALINE PHOSPHATASE INCREASED 144 0.0058
734 POST PROCEDURAL COMPLICATION 111 0.0058
735 LACTIC ACIDOSIS 187 0.0058
736 THERAPY PARTIAL RESPONDER 90 0.0058
737 INFLUENZA LIKE ILLNESS 474 0.0058
738 HAEMORRHAGE INTRACRANIAL 86 0.0057
739 NEOPLASM 66 0.0057
740 RESPIRATORY TRACT CONGESTION 91 0.0057
741 GASTROINTESTINAL PAIN 63 0.0057
742 BURNING SENSATION 401 0.0057
743 PULMONARY HYPERTENSION 119 0.0057
744 ILLNESS 586 0.0057
745 CARDIAC ARREST 469 0.0057
746 ANHEDONIA 149 0.0057
747 RESTLESS LEGS SYNDROME 103 0.0057
748 BLOOD POTASSIUM DECREASED 170 0.0056
749 DYSPHAGIA 536 0.0056
750 PAIN OF SKIN 151 0.0056
751 PULMONARY CONGESTION 73 0.0055
752 MYOCLONUS 66 0.0055
753 PHOTOSENSITIVITY REACTION 91 0.0055
754 INTERNATIONAL NORMALISED RATIO INCREASED 157 0.0055
755 RHABDOMYOLYSIS 229 0.0055
756 SNEEZING 123 0.0055
757 OCULAR HYPERAEMIA 260 0.0055
758 THYROID DISORDER 84 0.0054
759 OSTEONECROSIS 178 0.0054
760 GLAUCOMA 104 0.0054
761 TOOTH DISORDER 120 0.0054
762 EOSINOPHILIA 94 0.0054
763 SEIZURE 619 0.0054
764 ACUTE MYOCARDIAL INFARCTION 158 0.0054
765 ALTERED STATE OF CONSCIOUSNESS 116 0.0053
766 EYE DISORDER 176 0.0053
767 HYPOPHAGIA 136 0.0053
768 INTERVERTEBRAL DISC PROTRUSION 116 0.0053
769 SINUS DISORDER 105 0.0053
770 ACCIDENT 63 0.0053
771 NEUTROPHIL COUNT DECREASED 215 0.0053
772 FLATULENCE 298 0.0052
773 DRY EYE 261 0.0052
774 LIMB INJURY 141 0.0052
775 LIMB DISCOMFORT 160 0.0052
776 DRUG INTERACTION 816 0.0051
777 HYPERHIDROSIS 662 0.0051
778 HEMIPARESIS 87 0.0051
779 IMPAIRED GASTRIC EMPTYING 70 0.0051
780 CHOLELITHIASIS 168 0.0051
781 RASH GENERALISED 132 0.0051
782 DISEASE PROGRESSION 601 0.0051
783 RIB FRACTURE 104 0.0051
784 INSURANCE ISSUE 77 0.0050
785 HEAD DISCOMFORT 89 0.0050
786 PROTEINURIA 95 0.0050
787 URINARY INCONTINENCE 148 0.0050
788 BONE DISORDER 91 0.0050
789 EPISTAXIS 373 0.0050
790 FAECES DISCOLOURED 108 0.0050
791 ACUTE HEPATIC FAILURE 68 0.0050
792 NERVOUS SYSTEM DISORDER 155 0.0050
793 SINUS CONGESTION 67 0.0050
794 DIVERTICULITIS 137 0.0049
795 EATING DISORDER 105 0.0049
796 THROMBOSIS 396 0.0049
797 HOT FLUSH 370 0.0049
798 SYNCOPE 491 0.0049
799 SCAR 84 0.0049
800 HAEMATEMESIS 124 0.0049
801 DYSPHONIA 286 0.0049
802 BONE PAIN 286 0.0049
803 FALL 1625 0.0049
804 FEEDING DISORDER 99 0.0049
805 BLOOD TRIGLYCERIDES INCREASED 86 0.0049
806 BLOOD POTASSIUM INCREASED 79 0.0049
807 MYALGIA 827 0.0049
808 TRANSIENT ISCHAEMIC ATTACK 164 0.0049
809 DYSGEUSIA 360 0.0048
810 MELAENA 106 0.0048
811 LIVER FUNCTION TEST ABNORMAL 140 0.0048
812 DIPLOPIA 125 0.0048
813 APHONIA 67 0.0048
814 MASS 67 0.0048
815 BEDRIDDEN 63 0.0048
816 SPINAL FRACTURE 96 0.0048
817 HAEMATOMA 124 0.0048
818 CARPAL TUNNEL SYNDROME 67 0.0048
819 ACUTE MYELOID LEUKAEMIA 74 0.0047
820 DISORIENTATION 188 0.0047
821 DEPRESSED LEVEL OF CONSCIOUSNESS 187 0.0047
822 LOSS OF CONSCIOUSNESS 605 0.0047
823 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 110 0.0047
824 INTENTIONAL PRODUCT MISUSE 412 0.0047
825 PLATELET COUNT DECREASED 497 0.0047
826 HERNIA 90 0.0046
827 NEOPLASM PROGRESSION 161 0.0046
828 DRUG ERUPTION 82 0.0046
829 CATARACT 274 0.0046
830 GASTRIC ULCER 87 0.0046
831 PERITONITIS 94 0.0045
832 APHASIA 137 0.0045
833 DYSARTHRIA 170 0.0045
834 DRUG RESISTANCE 116 0.0045
835 RETCHING 96 0.0045
836 DIABETIC KETOACIDOSIS 108 0.0045
837 RENAL IMPAIRMENT 377 0.0045
838 POLLAKIURIA 187 0.0045
839 SKIN CANCER 96 0.0045
840 DRUG EFFECT LESS THAN EXPECTED 66 0.0044
841 CHROMATURIA 100 0.0044
842 SKIN BURNING SENSATION 317 0.0044
843 MUSCULOSKELETAL DISCOMFORT 76 0.0044
844 ATRIAL FIBRILLATION 427 0.0044
845 THIRST 78 0.0044
846 PRODUCT PRESCRIBING ISSUE 95 0.0044
847 BLOOD URINE PRESENT 82 0.0043
848 FULL BLOOD COUNT DECREASED 87 0.0043
849 HALLUCINATION, VISUAL 91 0.0043
850 MUSCLE TWITCHING 99 0.0043
851 CARDIO-RESPIRATORY ARREST 179 0.0043
852 HYPERSOMNIA 122 0.0043
853 URINARY RETENTION 142 0.0043
854 DISTURBANCE IN ATTENTION 229 0.0042
855 PRODUCT DOSE OMISSION IN ERROR 120 0.0042
856 HAEMORRHAGE 443 0.0042
857 PRODUCT ADMINISTRATION ERROR 85 0.0042
858 TREMOR 698 0.0042
859 PRODUCT QUALITY ISSUE 570 0.0042
860 BLOOD PRESSURE ABNORMAL 83 0.0042
861 MOVEMENT DISORDER 134 0.0042
862 UPPER LIMB FRACTURE 83 0.0042
863 EYE PAIN 235 0.0042
864 ISCHAEMIC STROKE 74 0.0041
865 DEPRESSED MOOD 219 0.0041
866 HEAD INJURY 131 0.0041
867 ELECTROCARDIOGRAM QT PROLONGED 148 0.0041
868 GASTROINTESTINAL HAEMORRHAGE 343 0.0041
869 SPEECH DISORDER 215 0.0041
870 UPPER GASTROINTESTINAL HAEMORRHAGE 69 0.0041
871 DYSSTASIA 119 0.0041
872 PRODUCT PRESCRIBING ERROR 96 0.0040
873 PRURITUS GENERALISED 87 0.0040
874 WHITE BLOOD CELL COUNT DECREASED 431 0.0040
875 HAEMATURIA 136 0.0040
876 MENTAL DISORDER 171 0.0039
877 CEREBRAL HAEMORRHAGE 140 0.0039
878 ANGINA PECTORIS 112 0.0039
879 INTENTIONAL DOSE OMISSION 111 0.0039
880 HEPATIC FUNCTION ABNORMAL 144 0.0039
881 MIDDLE INSOMNIA 72 0.0039
882 JAUNDICE 103 0.0038
883 SKIN IRRITATION 174 0.0038
884 VISION BLURRED 520 0.0038
885 RESPIRATORY ARREST 104 0.0038
886 AGITATION 277 0.0038
887 CARDIAC FAILURE 301 0.0037
888 INCORRECT DOSE ADMINISTERED 849 0.0037
889 BALANCE DISORDER 316 0.0037
890 AGEUSIA 91 0.0036
891 IRRITABILITY 219 0.0036
892 RESTLESSNESS 133 0.0036
893 THINKING ABNORMAL 67 0.0036
894 PSYCHOTIC DISORDER 105 0.0036
895 MALIGNANT NEOPLASM PROGRESSION 364 0.0036
896 PRODUCT DOSE OMISSION ISSUE 1043 0.0035
897 HOSPITALISATION 544 0.0035
898 CHOKING 69 0.0035
899 PANIC ATTACK 128 0.0035
900 BLOOD CREATINE PHOSPHOKINASE INCREASED 100 0.0035
901 PELVIC PAIN 63 0.0035
902 BLINDNESS 141 0.0035
903 INCREASED APPETITE 66 0.0035
904 SEROTONIN SYNDROME 65 0.0034
905 FEELING ABNORMAL 803 0.0033
906 INTERSTITIAL LUNG DISEASE 161 0.0033
907 OSTEONECROSIS OF JAW 82 0.0033
908 RENAL INJURY 97 0.0033
909 HYPOACUSIS 140 0.0032
910 CARDIAC FAILURE CONGESTIVE 261 0.0032
911 NERVOUSNESS 168 0.0032
912 DEMENTIA 89 0.0032
913 INJECTION SITE PRURITUS 213 0.0032
914 CEREBROVASCULAR ACCIDENT 538 0.0032
915 MOOD SWINGS 101 0.0032
916 THERAPEUTIC RESPONSE UNEXPECTED 141 0.0031
917 CRYING 114 0.0031
918 CONVULSION 179 0.0031
919 COMA 148 0.0031
920 EYE IRRITATION 178 0.0031
921 HALLUCINATION 233 0.0031
922 DEAFNESS 79 0.0030
923 PLASMA CELL MYELOMA 117 0.0030
924 ARRHYTHMIA 142 0.0030
925 WITHDRAWAL SYNDROME 125 0.0030
926 GASTRIC DISORDER 102 0.0030
927 CEREBRAL INFARCTION 72 0.0029
928 SURGERY 172 0.0029
929 HIP FRACTURE 93 0.0029
930 ACNE 218 0.0029
931 AGGRESSION 143 0.0029
932 CARDIOVASCULAR DISORDER 72 0.0028
933 PRODUCT SUBSTITUTION ISSUE 163 0.0028
934 DYSKINESIA 115 0.0028
935 INJECTION SITE URTICARIA 69 0.0028
936 MENTAL IMPAIRMENT 67 0.0028
937 OVERDOSE 593 0.0027
938 RENAL DISORDER 127 0.0027
939 MOOD ALTERED 74 0.0027
940 COGNITIVE DISORDER 126 0.0027
941 BONE DENSITY DECREASED 83 0.0026
942 ERECTILE DYSFUNCTION 68 0.0026
943 EMOTIONAL DISTRESS 313 0.0026
944 DEVICE DISLOCATION 112 0.0026
945 BLOOD GLUCOSE DECREASED 123 0.0026
946 FEMUR FRACTURE 79 0.0025
947 INJECTION SITE RASH 78 0.0025
948 MYELOSUPPRESSION 89 0.0025
949 EXPIRED PRODUCT ADMINISTERED 82 0.0025
950 DEVICE BREAKAGE 100 0.0025
951 NEOPLASM MALIGNANT 164 0.0025
952 ABORTION SPONTANEOUS 98 0.0024
953 SUICIDAL IDEATION 220 0.0024
954 EMOTIONAL DISORDER 74 0.0024
955 TOXICITY TO VARIOUS AGENTS 391 0.0023
956 VISUAL ACUITY REDUCED 77 0.0023
957 ABNORMAL BEHAVIOUR 90 0.0023
958 CARDIAC DISORDER 211 0.0023
959 NEEDLE ISSUE 64 0.0022
960 DRUG DOSE OMISSION BY DEVICE 171 0.0022
961 DRUG EXPOSURE DURING PREGNANCY 74 0.0022
962 THERAPY INTERRUPTED 155 0.0022
963 DEVICE LEAKAGE 94 0.0022
964 INJECTION SITE SWELLING 164 0.0021
965 UNEVALUABLE EVENT 160 0.0021
966 INJECTION SITE ERYTHEMA 253 0.0020
967 DEATH 1751 0.0020
968 BLOOD GLUCOSE INCREASED 382 0.0020
969 INJECTION SITE BRUISING 158 0.0020
970 MYOCARDIAL INFARCTION 338 0.0019
971 PRODUCT DOSE OMISSION 126 0.0019
972 DEVICE MALFUNCTION 133 0.0019
973 INJECTION SITE MASS 67 0.0018
974 INJECTION SITE PAIN 544 0.0018
975 DRUG EFFECT DECREASED 94 0.0017
976 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 81 0.0017
977 DEVICE ISSUE 151 0.0017
978 NO ADVERSE EVENT 297 0.0016
979 MULTIPLE SCLEROSIS 78 0.0016
980 THERAPY CESSATION 79 0.0015
981 VAGINAL HAEMORRHAGE 64 0.0015
982 SUICIDE ATTEMPT 83 0.0014
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 93 0.0013
984 DRUG DOSE OMISSION 215 0.0013
985 INJECTION SITE HAEMORRHAGE 100 0.0013
986 INTENTIONAL OVERDOSE 80 0.0012
987 DRUG DEPENDENCE 175 0.0011
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 213 0.0011
989 BREAST CANCER 83 0.0009
990 ACCIDENTAL EXPOSURE TO PRODUCT 91 0.0009
991 DRUG WITHDRAWAL SYNDROME 73 0.0008